VCP and urinary bladder cancer: Altogether, these in vivo results suggest that a single dose of the p97 inhibitor CB-5083 at 25 mg/kg reduces the growth of bladder cancer xenografts treated with IR, with no exacerbation of acute normal tissue toxicity to the surrounding small intestine of CD-1 nude mice under the observed conditions.